Medindia

X

Essilor Sells its Stake in Sperian Protection

Wednesday, May 19, 2010 General News J E 4
Advertisement
CHARENTON-LE-PONT, France, May 19, 2010 SperianProtection's Board of Directors agreed this morning to accept Honeywell'svoluntary tender offer to acquire 100% of its capital at a price of EUR117per share.

Essilor has agreed to sell all of its Sperian Protection shares toHoneywell in an off-market transaction, based on the offering price of EUR117per share, subject to certain conditions (approval from the European and USregulatory authorities, as well as the French Ministry of the Economy,Industry and Employment).

The world leader in ophthalmic optical products, Essilor Internationalresearches, develops, manufactures and markets around the world a wide rangeof lenses to improve and protect eyesight. Its flagship brands areVarilux(R), Crizal(R), Essilor(R), Definity(R) and Xperio(TM).

Based in France, the company reported consolidated revenue of more thanEUR3.2 billion in 2009, with 34,700 employees and operations in 100 countries.

For more information, please visit http://www.essilor.com.

The Essilor share trades on the NYSE Euronext Paris market and isincluded in the CAC 40 index.

Codes and symbols: ISIN: FR FR0000121667; Reuters: ESSI.PA; Bloomberg:EI:FP.Investor Relations and Financial Communications Veronique Gillet - Sebastien Leroy Phone: +33-(0)1-49-77-42-16 invest@essilor.com

SOURCE Essilor
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Red Cross Survey Finds More Than Two-thirds of Ame...
S
Horizon Pharma, Inc. Presents Interim Results from...